FK506 increases permeability in rat intestine by inhibiting mitochondrial function
- PMID: 7540994
- DOI: 10.1016/0016-5085(95)90274-0
FK506 increases permeability in rat intestine by inhibiting mitochondrial function
Abstract
Background & aims: Under normal physiological conditions, the intestine presents an adenosine triphosphate (ATP)-dependent barrier to luminal contents. Disruption of this barrier function can occur when cellular metabolism is compromised. This study examined the effects of FK506 on intestinal permeability and enterocyte metabolic function in Lewis rats.
Methods: Rats were administered FK506 at a dose of 0.1, 0.5, or 2 mg/kg on alternate days for 6 weeks. Intestinal permeability was assessed by measuring urinary recovery of 99mTc-diethylenetriamine pentacetate, and electrophysiological conductance measurements were performed in Ussing chambers. Metabolic function was assessed in isolated enterocytes by measuring total ATP and CO2 release from [14C]pyruvate and [14C]glucose.
Results: Rats treated with FK506 showed a dose-dependent reduction in weight gain as well as increased in vivo and in vitro intestinal permeability. There was no difference in plasma creatinine or urinary output. Changes in permeability correlated with reduced ATP levels and CO2 release because of diminished mitochondrial function. Lactate production, as a measure of glycolytic activity, was not altered by FK506.
Conclusions: In a dose-dependent manner, FK506 treatment in rats reduces weight gain, increases intestinal permeability, and decreases the ability of the small intestine to use glucose as an energy source.
Similar articles
-
Tacrolimus (FK506)--its effects on intestinal glucose transport.Transplantation. 1996 Feb 27;61(4):630-4. doi: 10.1097/00007890-199602270-00019. Transplantation. 1996. PMID: 8610392
-
Small-bowel permeability in collagenous colitis.Scand J Gastroenterol. 2006 Sep;41(9):1044-9. doi: 10.1080/00365520600554535. Scand J Gastroenterol. 2006. PMID: 16938717
-
Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.BMC Gastroenterol. 2007 Jun 19;7:23. doi: 10.1186/1471-230X-7-23. BMC Gastroenterol. 2007. PMID: 17578566 Free PMC article. Clinical Trial.
-
The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.Neurobiol Dis. 1997;4(3-4):288-300. doi: 10.1006/nbdi.1997.0146. Neurobiol Dis. 1997. PMID: 9361306 Review.
-
Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?J Neurosci Res. 2005 Jan 1-15;79(1-2):231-9. doi: 10.1002/jnr.20292. J Neurosci Res. 2005. PMID: 15573402 Review.
Cited by
-
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity.J Exp Med. 2008 Apr 14;205(4):897-913. doi: 10.1084/jem.20071046. Epub 2008 Mar 31. J Exp Med. 2008. PMID: 18378796 Free PMC article.
-
Post-transplantation Development of Food Allergies.Curr Allergy Asthma Rep. 2018 Jan 29;18(1):4. doi: 10.1007/s11882-018-0760-3. Curr Allergy Asthma Rep. 2018. PMID: 29380059 Review.
-
Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29).J Gastroenterol. 1997 Oct;32(5):605-10. doi: 10.1007/BF02934109. J Gastroenterol. 1997. PMID: 9349985
-
Modulating autism spectrum disorder pathophysiology using a trace amine-focused approach: targeting the gut.Mol Med. 2025 May 20;31(1):198. doi: 10.1186/s10020-025-01232-3. Mol Med. 2025. PMID: 40394473 Free PMC article. Review.
-
Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium.Gut. 2014 May;63(5):711-9. doi: 10.1136/gutjnl-2012-303731. Epub 2013 May 15. Gut. 2014. PMID: 23676441 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
